What is required to document the transfer of controlled substances?

The requirement to document the transfer of controlled substances includes specifying the date of the transaction and details of the controlled substance involved. This documentation is essential for maintaining a clear and accurate record of controlled substances as mandated by federal regulations under the DEA. It helps ensure accountability and traceability, which are critical in preventing diversion and ensuring compliance with legal requirements.

By documenting the date and the specific details of the controlled substance, such as the name, dosage form, strength, and quantity, pharmacies and other entities can create a comprehensive record that can be audited or reviewed if necessary. This documentation also plays a pivotal role in inventory management and in the event of investigations related to controlled substance misuse.

In contrast, simply noting the quantity or including information unrelated to the controlled substances would not fulfill regulatory requirements, and failing to document such transfers entirely would contradict established protocols for handling controlled substances.